Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma.

International journal of STD & AIDS - 1 Nov 2006

Maniar Janak K, Damond Florence, Kamath Ratnakar R, Mandalia Sundhiya, Surjushe Amar

Abstract excerpt

HIV-2 drug resistance in a case of dual HIV infection presents a formidable challenge to the treating physician. We report a patient with dual infection on highly active antiretroviral therapy (HAART) since March 2001 presented with clinical failure. Laboratory assays showed undetectable HIV-1 vi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Multiple, Viral
Share to HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation

Source

Identifiers

PMID: 17062187
DOI: 10.1258/095646206778691059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17062187-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma.PMID 17062187Read ↗

Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review.Semantic proximity Read ↗

Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infection.Semantic proximity Read ↗

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc.Semantic proximity Read ↗

Raltegravir treatment response in an HIV-2 infected patient: a case reportSemantic proximity Read ↗

Managing resistance to anti-HIV drugs: an important consideration for effective disease management.Semantic proximity Read ↗

Drug resistance mutations in patients infected with HIV-2 living in SpainSemantic proximity Read ↗

Special Aspects of the Treatment of HIV-2-Infected PatientsSemantic proximity Read ↗

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.Semantic proximity Read ↗

Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure.Semantic proximity Read ↗

Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs).Semantic proximity Read ↗

Successful virological outcome in an HIV-infected individual with a three-class resistant variant and an insertion in the protease genome with a Tipranavir based regimen.Semantic proximity Read ↗

Therapy failure resulting from superinfection by a drug-resistant HIV variant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.